Status:
COMPLETED
Genicular Nerve Block in Chronic Knee Osteoarthritis
Lead Sponsor:
Haydarpasa Numune Training and Research Hospital
Conditions:
Gonarthrosis; Primary
Genicular Nerve Block
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate whether genicular nerve block (GNB) is effective in reducing pain in patients with knee osteoarthritis. It will also assess the comparative efficacy of d...
Eligibility Criteria
Inclusion
- age between 45 and 75
- diagnosed with knee osteoarthritis (OA) according to the American College of Rheumatology (ACR) criteria
- possessing a Kellgren-Lawrence radiological grade of 2-3
Exclusion
- any joint injection to the target knee in the past 3 months
- physical therapy for the target knee within the last 3 months
- previous knee surgery
- inflammatory rheumatic diseases
- active lumbar radiculopathy on the same side
- neurological disorders (e.g., Alzheimer's or dementia)
- uncontrolled cardiopulmonary diseases
- pregnancy or lactation
- obesity (body mass index \[BMI\] \>35)
- presence of a pacemaker
- active malignancy
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT07174167
Start Date
April 1 2023
End Date
July 1 2024
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haydarpasa Numune Training and Research Hospital
Istanbul, Turkey (Türkiye)